Aramark's Growth Story Isn't Over Yet

Revenue rose from $16.08B in 2023 to $18.51B in 2025, and 2026 guidance targets $19.55–$19.95B (implying ~5.6%–7.8% growth vs. 2025) with adjusted EPS guidance of $2.18–$2.28. An analyst rates Aramark 'Buy' citing attractive valuation and strong execution in core food and facilities services; Business & Industry and international segments, refreshment services and AI-enabled supply-chain tools are highlighted as key growth drivers. The update is a constructive fundamental signal and could support low-single-digit upside in the stock.

Analysis

Aramark’s incremental edge comes from operational leverage in low-capex service categories plus targeted AI-driven supply chain improvements — expect a 75–150bps gross margin tailwind over the next 12–24 months as inventory turns rise and shrinkage/overbuying falls. That margin benefit is non-linear: each 1–2 day reduction in inventory turns translates to several hundred basis points of incremental free cash flow conversion given Aramark’s working-capital-heavy model, enabling either faster deleveraging or higher buybacks if management chooses.

Second-order winners include specialty packaging and single-serve suppliers who will see product mix shifts as corporate refreshment and catered services scale; packaging names should see volume growth earlier than broadline food distributors, which may experience margin compression as they compete for share. Conversely, legacy distributors and smaller tech-averse peers are at risk of losing procurement share — a 6–12 month window where incumbents with weaker tech stacks concede 100–300bps of margin to digitally enabled providers.

Main downside catalysts are macro-driven: a U.S. corporate capex/staffing pullback or a 10–15% step-up in key commodity proteins over a single quarter would quickly reverse margin momentum; execution risk on the AI rollout also matters — if implementation consumes ~1–2% of revenue in extra costs or causes service disruptions, the stock’s multiple will re-rate within months. Near-term event risks to watch: next quarter’s guidance cadence and any commentary on working capital or pilot-to-scale timelines for AI tools, which will determine whether the market prices in durable operating leverage or only transient revenue growth.

Key Decisions for Investors

• Long ARMK (12–18 months): buy shares with a 25–35% upside target and a tactical stop at -12%. Rationale: realize 75–150bps margin expansion + cash conversion; time horizon 12–24 months for AI benefits to show through to EPS.
• Call-spread alternative (9–15 months): buy ARMK long-dated call / sell higher strike call to fund ~60–80% of premium. Target asymmetric payoff if ARMK +25–40% by expiry; max loss = net premium (~3–6% of notional), max gain capped but returns 2–4x if thesis plays out.
• Relative-value pair (12 months): long ARMK / short Compass Group (CPG.L) sized 1:1 exposure. Rationale: overweight U.S. B&I and tech-enabled share gains versus Europe-exposed peer; target relative outperformance of 8–12% if U.S. corporate spend remains resilient.
• Tactical supply-chain play (6–12 months): buy packaging exposure (PKG or IP) as a leveraged way to play rising single-serve and catering volumes. Size modest (3–5% portfolio) and take profits on a 20–30% move, because these names are more cyclical and sensitive to commodity swings.